Form 4: Gilead Sciences Executive Sells Shares
Insider Transaction (Form 4)
Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, Inc., sold 3,000 shares of common stock on September 15, 2026.
Summary
- Open-market sale: disposed of 1,600 Common Stock at $143.69 ($229,907) on September 15, 2026; holds 118,084 after (Direct).
- Open-market sale: disposed of 800 Common Stock at $144.46 ($115,566) on September 15, 2026; holds 117,284 after (Direct).
- Open-market sale: disposed of 600 Common Stock at $145.29 ($87,174) on September 15, 2026; holds 116,684 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $432,646 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Johanna Mercier — Officer (Chief Comm & Corp Aff Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Stock | 1,600 | $144 | $229.9K | 118,084 |
| 2026-09-15 | Open-market sale | Common Stock | 800 | $144 | $115.6K | 117,284 |
| 2026-09-15 | Open-market sale | Common Stock | 600 | $145 | $87.2K | 116,684 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (1,600 shares) |
| 2026-09-15 | Open-market sale (800 shares) |
| 2026-09-15 | Open-market sale (600 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., bearish, Johanna Mercier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.